iSOFT Wins First Lorenzo Customer in Spain

iSOFT Group LimitediSOFT Group Limited (ASX:ISF) has agreed a €1 million contract for Lorenzo Enterprise with Spain's Cerdanya Cross-Border Hospital Private Foundation, an acute care facility at the border of Catalonia and France and the first to support a cross-national healthcare model between the two countries under the European Grouping for Territorial Cooperation.

Under the project, iSOFT will develop an enterprise-wide clinical and hospital management system for the 216-bed Cerdanya Hospital, an elderly care centre and seven primary care clinics in the French region of Capcir and the Cerdanya region of Catalonia and France.

Lorenzo Enterprise will manage all clinical services. Integration with iSOFT's hospital, electronic patient record and primary care solutions and third-party applications, using iSOFT's Viaduct integration platform, will provide a complete enterprise-wide, clinical and patient information management solution.

The solutions will be available to users in Spanish, Catalan and French languages and to several government authorities for management of finances and waiting lists.

Under the two-year deal, iSOFT will also migrate the solution to the new Cerdanya hospital currently under construction and due to open in two years.

The Cerdanya Cross-Border Hospital Private Foundation deals with over 90,000 outpatient appointments annually and covers a population of 30,000, although this can rise to 150,000 during the ski season.

"This represents another major milestone for Lorenzo and provides reference-ability in one of our key markets," said Andrea Fiumicelli, iSOFT's Chief Executive Officer. "This is a unique cross-border project demanding an advanced interoperable solution capable of managing a highly complex situation. A pioneering project, it fits perfectly with the European Union's e-health agenda for cross-border exchange of healthcare information."

The European Grouping for Territorial Cooperation is a new European legal instrument designed to facilitate and promote cross-border, transnational and interregional cooperation. It enables regional and local authorities and other public bodies from different member states to set up cooperation groupings as legal entities.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organizations.

Today, more than 13,000 provider organizations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 3,500 specialists in 19 countries worldwide.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...